Company Snapshot: BGEN  Print This Story  Email This Story  Save this Link View PR Newswire's RSS Feed  Blogs Discussing this News Release  Search Blogs that Mention this News Release  Click this link to view linked Bookmarking Services Click this link to view linked Blogging Services


Biogen Elects Boston Scientific CFO to its Board Of Directors

   BIOGEN LOGO
Biogen Logo. (PRNewsFoto)[KC]
CAMBRIDGE, MA USA
    CAMBRIDGE, Mass., Feb. 11 /PRNewswire-FirstCall/ --
Biogen, Inc. (Nasdaq: BGEN) today announced that Lawrence C. Best, Boston
Scientific's Senior Vice President and Chief Financial Officer, has been
elected to the Biogen Board of Directors.  The election took place at the
company's Board of Directors' meeting on February 7, 2003.
    (Photo: http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO )
    Mr. Best has served as Senior Vice President and Chief Financial Officer
for Boston Scientific since 1992.  Prior to his work with Boston Scientific,
Mr. Best was a partner in the accounting firm of Ernst & Young, where he
specialized in serving multinational companies in the high technology and life
sciences fields.  He served a two-year fellowship at the Securities & Exchange
Commission from 1979 to 1981 and a one-year term as a White House-appointed
Presidential Exchange Executive in Washington, D.C.
    James C. Mullen, Biogen's Chairman and Chief Executive Officer, said,
"Larry Best is a distinguished business leader whose expertise in corporate
finance has helped Boston Scientific realize considerable growth.  He is an
outstanding addition to our Board of Directors as Biogen seeks to achieve
continued operating success and pioneer new therapeutic advancements that help
improve the quality of patients' lives."

    About Biogen
    Biogen is the world's oldest independent biotechnology company and a
leader in biologics research, development and manufacturing.  A pioneer in
leading edge research in immunology, neurobiology and oncology, Biogen brings
novel therapies to improve patients' lives around the world through its global
marketing capabilities.  For press releases and additional information about
the company, please visit http://www.biogen.com.

    Media Contact:
     Amy Brockelman
     Manager, Public Affairs
     Biogen, Inc.
     Tel: (617) 914-6524

    Investment Community Contact:
     Christina Dillon
     Manager, Investor Relations
     Biogen, Inc.
     Tel: (617) 679-2812


SOURCE Biogen, Inc.




Back to Topback to top

Related links:
  • http://www.biogen.com
    Company News On-Call:
  • http://www.prnewswire.com/comp/101550.html
    Photo Notes:http://www.newscom.com/cgi-bin/prnh/19990824/BIOLOGO
    AP Archive: http://photoarchive.ap.org
    PRN Photo Desk, 888-776-6555 or 212-782-2840
    CONTACT:
    Media, Amy Brockelman, Manager, Public
    Affairs, +1-617-914-6524, or Investment, Christina Dillon,
    Manager, Investor Relations, +1-617-679- 2812, both of Biogen,
    Inc.